• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2020

View Archived Issues

Junshi Biosciences provides updates on JS-108 and JS-006 studies

Read More

FDA accepts IND for CERC-803 to treat leukocyte adhesion deficiency type II

Read More

Phase III ACTIVATE trial of mitapivat in PK deficiency meets primary endpoint

Read More

RS-5614 studied in investigator-initiated trial for severe COVID-19

Read More

Combination enhances solid tumor immunotherapy

Read More

Edesa initiates phase II/III study of EB-05 for hospitalized patients with COVID-19

Read More

Investigator-initiated trial to study Carragelose nasal spray for COVID-19 prophylaxis

Read More

Preliminary week 18 phase Ib/IIa data reported for HST-001 in androgenic alopecia

Read More

Rafael Pharmaceuticals to launch phase II study of CPI-613 in clear cell sarcoma of soft tissue

Read More

Agenus initiates phase II expansion of AGEN-1181 plus balstilimab in colon cancer

Read More

DMC completes positive safety review of CYNKCOVID study

Read More

Korea Research Institute of Bioscience and Biotechnology patents peptides for IBD

Read More

New USP19 inhibitors described by Integral Health Holdings, Valo Early Discovery

Read More

Aligos Therapeutics discovers STING agonists

Read More

FDA grants accelerated approval to Gavreto for advanced or metastatic RET-altered thyroid cancers

Read More

Prodrugs of TLR7 and TLR8 antagonists identified at Bristol Myers Squibb

Read More

New JAK inhibitors patented by Vimalan Biosciences

Read More

FDA approves Xolair to treat nasal polyps

Read More

Hetlioz approved in U.S. for nighttime sleep disturbances in Smith-Magenis syndrome

Read More

Investigators develop a swine model of abdominal aortic aneurysm

Read More

Targovax reports phase I data on ONCOS-102 with pembrolizumab in advanced melanoma

Read More

Novel rat models of doxorubicin-induced left ventricular dysfunction

Read More

A-3907 targets bile acid transport in the intestine and kidney for treating NASH, fibrosis

Read More

Ashvattha Therapeutics presents htHD-FXRa for treating hepatic and biliary disorders

Read More

Akeso reports preliminary data on cadonilimab for MSI-H advanced solid tumors

Read More

FDA clears IND for phase I study of DHOHD inhibitor RP-7214 for COVID-19

Read More

NEPTUNE study of OV-101 for Angelman syndrome misses primary endpoint

Read More

U.K. approval for Pfizer and BioNTech's COVID-19 mRNA vaccine BNT-162b2

Read More

IND for phase I study of SSAO/VAP-1 inhibitor TT-01025 cleared in U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe